BioCorRx Inc. (BICX): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$592.1K
As of 2020-12-31
+21.9%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $592.1K | -77.6% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $2.65M | n/a | 2021-03-31, Balance as of period end |
| No annual figure between 2015-12-31 and 2019-12-31. | |||
| 2015-12-31 | $220.1K | +314.3% | 2016-04-14, Balance as of period end |
| 2014-12-31 | $53.1K | -51.1% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $108.6K | n/m | 2015-03-31, Balance as of period end |
| 2012-12-31 | $6.0K | +262.2% | 2014-04-14, Balance as of period end |
| 2011-12-31 | $1.7K | -76.8% | 2013-04-15, Balance as of period end |
| 2010-12-31 | $7.1K | n/a | 2012-05-18, Balance as of period end |